Article
Comprehensive circulating tumor DNA mutation profiling via CAPP-Seq liquid biopsy for cervical cancer.
International journal of clinical oncology - 1 May 2026
Iwahashi Naoyuki, Noguchi Tomoko, Sakai Kazuko, Yahata Tamaki, Nishioka Kaho, Fujino Megumi, Takeda Shinichiro, Suzuki Nobuhiko, Nishio Kazuto, Ino Kazuhiko
Abstract excerpt
BACKGROUND: Liquid biopsy using circulating tumor DNA (ctDNA) is a minimally invasive approach for detecting tumor-associated genomic alterations. Although ctDNA analysis has been widely explored in solid tumors, its application to cervical cancer remains limited. Cancer personalized profiling by deep sequencing (CAPP-Seq) enables sensitive ctDNA profiling via molecular barcoding and digital error suppression....
Topics
Join the communities discussing this publication.
